Understanding congestive heart failureFebruary 5, 2019Congestive heart failure (CHF) is described by medical professionals as more of a syndrome than a disease. Yet, when pet owners are often attuned to "disease," how can veterinarians best convey what CHF really is to their clients? "Congestive heart failure can result from a variety of different types of underlying heart disease," says Emily Karlin, DVM, Dipl. (cardiology), clinical instructor at Cummings School of Veterinary Medicine at Tufts University. "When we say CHF, we generally are referring to fluid buildup somewhere it should not be, as a result of heart dysfunction. We can see left-sided CHF (fluid buildup in the lungs—pulmonary edema), resulting in cough or trouble breathing, or right-sided CHF (fluid buildup in the abdomen or around the lungs—ascites or pleural effusion), resulting in abdominal distension or trouble breathing. Basically, CHF is a potential outcome of having heart disease." Recognizing signs and symptoms When it comes to differentiating CHF from heart disease, paying attention to clinical signs and symptoms is key. "Asymptomatic, or occult, heart disease is often detected based on physical exam abnormalities—such as a heart murmur, cardiac gallop, or arrhythmia—or sometimes by echocardiographic screening, but the animal is feeling well at home with no clinical …
SPONSORED CONTENTLife-saving results for parvovirus casesResearch has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients. + Read More
What makes a good working dog?February 5, 2019The canine labor market is diverse and expansive. Assistance dogs may be trained to work with the visually or hearing impaired, or with people in wheelchairs. Detection dogs may be trained to sniff out explosives, narcotics, or bedbugs. Others even learn to jump out of helicopters on daring rescue missions. Despite the wide variety of working roles available for man's best friend, those jobs can be tough to fill, since not every dog will qualify. Even among those specifically bred to be assistance dogs, only about 50 percent starting a training program will successfully complete it, while the rest go on to be very well-trained family pets. As a result, the wait list for a trained assistance dog can be up to two years. Evan MacLean, PhD, director of the Arizona Canine Cognition Center at the University of Arizona (UA), is exploring ways to identify the best dogs for different jobs—before they start the long and expensive training process—by looking at their cognitive abilities. He is lead author of a study in Frontiers in Veterinary Science looking at whether canines' cognitive abilities can help predict their success as working dogs. While a dog's physical characteristics and temperament are often considered …
How 3-D printing benefits presurgical planning for angular limb deformityFebruary 4, 2019 The surgical treatment of limb deformities in dogs has historically been approached by taking preoperative measurements using radiographic orthogonal views. When calculations for the osteotomy location, hardware type, and size were determined, the information was transferred to the patient in the operating theatre. Although using this procedure can result in satisfactory outcomes, there are many cases involving severe deformities where preoperative planning can be very difficult. Having a 3-D model closely approximating the actual limb can significantly benefit the preoperative plan. Enter 3-D printing Three-dimensional printing (3DP) is proving to be a very useful technique in veterinary orthopedic applications, particularly as it relates to preoperative planning. Production of multiple models that are scaled on a one-to-one ratio to the patient can allow the surgeon to accurately plan surgical procedures. Using these techniques for preoperative planning can provide several benefits, including lessening time under anesthesia and lowering its associated risks, as well as decreasing surgical site infection. Although it is expensive, the cost of employing 3DP can be justified when considering the benefit of shorter surgeries, less anesthetic time, and facilitating more consistent results to avoid subsequent revision surgeries. In the majority of cases, the use of 3-D modeling is …
Dog DNA company discovers why huskies have blue eyesOctober 8, 2018A duplication on canine chromosome 18 is behind Siberian huskies' blue eyes, according to a study published in PLOS Genetics by Adam Boyko, PhD, founder and CEO of Embark Veterinary, and Aaron Sams, PhD, senior scientist at Embark Veterinary Inc. and colleagues. According to the authors, this is the first consumer genomics study conducted in a nonhuman model and the largest canine genome-wide association study to date (the DNA of 6,000 dogs was tested). Embark Veterinary is a DNA research company with offices in Boston and Ithaca, N.Y., and a research partner of the Cornell University College of Veterinary Medicine. Boyko, Sams, and colleagues used a diverse panel of 6,070 genetically tested dogs from owners that contributed phenotype data via web-based surveys and photo uploads. They found that a 98.6-kilobase duplication on chromosome 18 near the ALX4 gene, which plays an important role in mammalian eye development, was strongly associated with variation in blue eye color, primarily in Siberian huskies but also in nonmerle Australian shepherds. One copy of the variant was enough to cause blue eyes, or heterochromia. However, some dogs with the variant did not have blue eyes, so other genetic or environmental factors are still involved. …
VolitionRx tests nucleosome diagnostic for veterinary space applicationsOctober 5, 2018 VolitionRx Ltd., a multinational Belgium-based life sciences company with offices in Texas, London, and Singapore, announced it is entering the veterinary market after "very encouraging" preliminary results from a study using its NuQ diagnostic blood tests for canine cancer testing. NuQ, currently used to screen for colorectal and prostate cancers, works by measuring and analyzing irregular levels of nucleosomes—a section of DNA wrapped around a core of proteins—in the blood to identify cancers. According to the company, the proof-of-concept study showed that blood nucleosomes also can be detected in dogs. With the promise of veterinary medicine applications, VolitionRx said it will now move NuQ into larger trials to answer the question of whether the method will work with animals. The company said it intends to outsource much of the veterinary clinical trial work through a partnership with Heather Wilson-Robles, DVM, DACVIM, associate professor and Fred and Vola N. Palmer chair in comparative oncology with Texas A&M College of Veterinary Medicine & Biomedical Sciences in the Small Animal Clinical Sciences department. "The Texas A&M University College of Veterinary Medicine Oncology Department is excited for the opportunity to collaborate with Volition," said Dr. Wilson-Robles. "Its innovative work in …
Companion Animal Health targets mast cell tumors with nanomedicineOctober 4, 2018Companion Animal Health (CAH) in Newark, Del., has secured an exclusive partnership with Nanospectra Biosciences Inc., a medical device company focused on the use of nanomedicine in selective thermal ablation of solid tumors. In 2017, CAH initiated clinical trials in the treatment of canine mast cell tumors using a combined laser and nanoshell therapy procedure that has the ability to destroy solid tumors without damaging adjacent healthy tissue. "Initial results are very encouraging and we anticipate publishing trial outcomes in the near future," said Brian Pryor, PhD, CEO, LiteCure LLC. "We believe this approach will deliver superior efficacy compared to commonly used cancer treatments and will extend pets' quality of life and longevity without harmful side effects." Visit companionanimalhealth.com for more information.
UC Davis study applies human cancer differentiation analysis to dogsOctober 4, 2018The University of California, Davis, School of Veterinary Medicine (UCDSVM) is conducting a clinical trial to study the potential application for canine cancer screening using cancer differentiation analysis (CDA) liquid biopsy technology from Anpac Bio-Medical Science Co. Studying at least 186 dogs in a blinded clinical trial, Anpac Bio and UCDSVM are investigating CDA's ability to identify cancer in blood samples from dogs confirmed with sarcomas or carcinomas versus healthy control blood samples from dogs of similar age and breed. Following the initial screening, UCDVSM will then test if CDA levels also correlate to treatment response (i.e. if the dogs' cells are responding to cancer treatment such as surgery or radiation) and monitor remission/potential recurrence. "Dogs are just like people; the sooner we identify disease, the better chance we have in treating and curing it," said John Reddington, DVM, PhD, Anpac Bio's chief advisor for veterinary and comparative research. "Unfortunately, dogs can't tell us when they don't feel well, so, we often catch diseases like cancer late stage. [Anpac Bio's] cancer differentiation analysis liquid biopsy technology has proven to be very useful in detecting over 20 human cancer types with just a single …
Penn Vet doctors receive NIH grant to target canine autoimmune diseaseOctober 4, 2018Nicola J. Mason, BVetMed, PhD, and Aimee S. Payne, MD, PhD, have received the National Institutes of Health (NIH) Director's Transformative Research Award, part of the institute's High-Risk, High-Reward Research program, for their work in targeting autoimmune disease in dogs. Under the grant, Drs. Mason and Payne are looking to evaluate a genetically engineered cell-based therapy to treat dogs with naturally occurring autoimmune skin disease known as pemphigus. Dogs are one of the few other species to develop pemphigus, a condition that mirrors pemphigus in human patients. Evaluation of this approach to treat pet dogs with the disease may ultimately lead to breakthrough therapies for humans. According to the Autoimmune Disease Research Center at Johns Hopkins, at least 10 million Americans suffer from the more than 80 illnesses caused by autoimmunity. "The successful treatment of autoimmunity in the family dog using this unique approach would not only be a breakthrough in veterinary medicine, but could also change the way autoimmune disease is treated in humans," said Mason, associate professor of medicine and pathobiology at the School of Veterinary Medicine at Penn Vet. "We believe that this work may facilitate the translation of cellular immunotherapies for a broad range of canine …
Study: "Dog cognition does not look exceptional," researchers findOctober 3, 2018 Dogs may be smart cookies—just not quite the braniacs that many believe they are, according to research published in Learning & Behavior. In a study that examined more than 300 papers on the intelligence of dogs and other animals, researchers reviewed evidence that compared dogs' smarts with other domestic animals, other social hunters, and other carnivorans, such as wolves, bears, lions, and hyenas. What scientists from the U.K.'s University of Exeter and Canterbury Christ Church University discovered were that dogs' cognitive abilities were at least matched by several species in each of these groups as well as several cases where dogs' mental abilities suffered from "over interpretation." "During our work it seemed to us that many studies in dog cognition research set out to 'prove' how clever dogs are," said Stephen Lea, PhD, the study's principal author, from the University of Exeter. Lea went on to say that dogs' correct responses or actions are often compared to those of chimpanzees, but researchers found "in each and every case … other valid comparison species that do at least as well as dogs do in those tasks." The review focused on sensory cognition, physical cognition, spatial cognition, social cognition, and …
Royal Canin releases Pill Assist to help administer medication to dogs October 2, 2018Royal Canin has launched veterinary-exclusive Pill Assist soft chews to simplify administering medication to dogs. According to a study by the company, Pill Assist enabled successful pill administration in 97 percent of cases. "We understand the stress pet owners face when trying to provide necessary medication for their pets," said Catherine Lenox, DVM, CVA, DACVN, scientific affairs manager for Royal Canin. "A dog's medication cannot help if it is not taken. Royal Canin developed Pill Assist to ease the burden on pet owners and enable dogs to better consume the medication they need." The product's soft texture can be molded around any pill shape, is available in sizes for small and medium-to-large dogs, has moderate calorie content, and includes vitamins and prebiotics. The product can be found at select veterinary clinics.
